💊 Atea Pharmaceuticals’ hepatitis C pill matches Gilead’s Epclusa: The biotech said Tuesday that its combination therapy of bemnifosbuvir and ruzasvir (BEM/RZR) hit non-inferiority against Epclusa, a standard of care for ...